Introduction Executive Summary Vasculitis: Overview ● Causes ● Mechanism of Action ● Signs and Symptoms ● Diagnosis ● Disease Management Pipeline Therapeutics ● Comparative Analysis Therapeutic Assessment ● Assessment by Product Type ● Assessment by Stage and Product Type ● Assessment by Route of Administration ● Assessment by Stage and Route of Administration ● Assessment by Molecule Type ● Assessment by Stage and Molecule Type Vasculitis – DelveInsight’s Analytical Perspective In-depth Commercial Assessment ● Vasculitis companies’ collaborations, Licensing, Acquisition -Deal Value Trends Vasculitis Collaboration Deals ● Company-Company Collaborations (Licensing / Partnering) Analysis ● Company-University Collaborations (Licensing / Partnering) Analysis Late Stage Products (Preregistration) ● Comparative Analysis Avacopan: ChemoCentryx ● Product Description ● Research and Development ● Product Development Activities Drug profiles in the detailed report….. Mid Stage Products (Phase II) ● Comparative Analysis Vilobelimab: InflaRx ● Product Description ● Research and Development ● Product Development Activities Drug profiles in the detailed report….. Preclinical and Discovery stage ● Comparative Analysis CIT 013: Citryll ● Product Description ● Research and Development ● Product Development Activities Drug profiles in the detailed report….. Inactive Products ● Comparative Analysis Vasculitis Key Companies Vasculitis Key Products Vasculitis- Unmet Needs Vasculitis- Market Drivers and Barriers Vasculitis- Future Perspectives and Conclusion Vasculitis Analyst Views Vasculitis Key Companies Appendix

Table 1 Total Products for Vasculitis Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• ChemoCentryx • GlaxoSmithKline • Roche • AbbVie • InflaRx • CytoDyn • Toleranzia • Citryll • Levolta